Cytokine release syndrome
The field of immunotherapies including monoclonal antibodies and cellular therapies is rapidly evolving and cytokine release syndrome is an obstacle to deal with in this process. This syndrome is a kind of toxic condition caused by the pro-inflammatory cytokines released with the activation of the e...
Main Authors: | Esra Yildizhan, Leylagul Kaynar |
---|---|
Format: | Article |
Language: | English |
Published: |
Turkiye Klinikleri
2018-12-01
|
Series: | Journal of Oncological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452336418300517 |
Similar Items
-
Assessment of Post-transplantation Liver Function Tests in Patients Undergoing Allogeneic Stem Cell Transplantation
by: Melih Kızıltepe, et al.
Published: (2020-01-01) -
Cytokine release syndrome
by: Alexander Shimabukuro-Vornhagen, et al.
Published: (2018-06-01) -
Rituximab and Cytokine Release Syndrome
by: Hrishikesh S. Kulkarni, et al.
Published: (2012-03-01) -
Cytokine Release Syndrome: Current Perspectives
by: Murthy H, et al.
Published: (2019-10-01) -
Current Approach to Neutropenic Enterocolitis
by: Umran Sümeyse Ertürk, et al.
Published: (2020-04-01)